ESC Heart Failure, 2023 Aims This study aimed to determine the impact of heart failure (HF) on clinical outcomes in patients with atrial fibrillation (AF). Methods and results We analysed data from Polish participants of the EURObservational Research Programme‐AF General Long ...
Monika Budnik +13 more
doaj +1 more source
Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj +1 more source
Sodium-Glucose Co-transporter-2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Breakthrough in Improvement of Clinical Outcomes? [PDF]
, 2022 The conventional conception of the therapy of heart failure (HF) with reduced ejection fraction has been recently modified by adding sodium-glucose co-transporter-2 (SGLT2) inhibitors to the combination consisting of beta blockers, mineralocorticoid ...
Alexander A. Berezin +1 more
core +1 more source
Frontiers in Cardiovascular Medicine, 2022 BackgroundAlthough the predictive value of galectin-3 for heart failure with preserved ejection fraction has been demonstrated, the diagnostic value remains unclear.
Jing Jiang +5 more
doaj +1 more source
Efficacy of guideline-directed medical treatment in heart failure with mildly reduced ejection fraction. [PDF]
, 2022 Heart failure with mildly reduced ejection fraction (HFmrEF) has received increasing attention following the publication of the latest ESC guidelines in 2021.
Zhang, Yunlong +10 more
core +1 more source
The value of IGF-1 and IGFBP-1 in patients with heart failure with reduced, mid-range, and preserved ejection fraction [PDF]
, 2022 Background: Previous studies have reported inconsistent results regarding the implications of deranged insulin-like growth factor 1 (IGF-1)/insulin-like growth factor-binding protein 1 (IGFBP-1) axis in patients with heart failure (HF).
Tse, Gary +5 more
core +1 more source
Automated echocardiographic detection of heart failure with preserved ejection fraction using artificial intelligence [PDF]
, 2023 Background: Detection of heart failure with preserved ejection fraction (HFpEF) involves integration of multiple imaging and clinical features which are often discordant or indeterminate. Objectives: We applied artificial intelligence (AI) to analyze a
Lopez-Jimenez, F. +17 more
core +1 more source
The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
Cardiac Failure Review, 2022 Heart failure (HF) is a major health burden associated with significant morbidity and mortality. Approximately half of all HF patients have reduced ejection fraction (left ventricular ejection fraction
Rebecca C Gosling, Abdallah Al-Mohammad
doaj +1 more source
A novel three-dimensional and tissue Doppler echocardiographic index for diagnosing and prognosticating heart failure with preserved ejection fraction [PDF]
, 2022 Introduction: The diagnosis of heart failure with preserved ejection fraction (HFpEF) remains challenging. In this study, a novel echocardiography index based on three-dimensional and tissue Doppler echocardiography for diagnosing and estimating ...
Tse, Gary +10 more
core +1 more source
Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
Frontiers in Physiology, 2022 Heart failure with preserved ejection fraction is a growing epidemic and accounts for half of all patients with heart failure. Increasing prevalence, morbidity, and clinical inertia have spurred a rethinking of the pathophysiology of heart failure with ...
Aneesh Dhore-patil +7 more
doaj +1 more source